PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
Fundamental research into the mechanisms behind cancers at an institution in Japan is leading to new approaches for tackling these notoriously complex diseases. Every year, up to 20 million people in ...